Lobbying activity

Q2

GUIDEPOSTSTRATEGIES, LLC for UNITEDHEALTH GROUP, INC.

2nd Quarter (Apr 1 - June 30) 2025 · District of Columbia · House · Senate · $90,000.00 income

Health Issues, Medicare/Medicaid, Pharmacy

View → Q2

THE VOGEL GROUP for NEPHRON PHARMACEUTICALS CORPORATION

2nd Quarter (Apr 1 - June 30) 2025 · South Carolina · $45,000.00 income

Pharmacy

View → Q2

WALGREEN COMPANY for WALGREEN COMPANY

2nd Quarter (Apr 1 - June 30) 2025 · District of Columbia · House · Senate

Pharmacy, Consumer Issues/Safety/Products, Taxation/Internal Revenue Code

View → Q2

WINNING STRATEGIES WASHINGTON for KALEO

2nd Quarter (Apr 1 - June 30) 2025 · Virginia · House · Senate · $20,000.00 income

Health Issues, Pharmacy, Defense, Budget/Appropriations

View → Q2

NAVITUS HEALTH SOLUTIONS for NAVITUS HEALTH SOLUTIONS

2nd Quarter (Apr 1 - June 30) 2025 · Wisconsin · House · Senate

Health Issues, Insurance, Pharmacy

View → Q2

TODD STRATEGY GROUP for PHARMACEUTICAL RESEARCH AND MANUFACTURERS OF AMERICA

2nd Quarter (Apr 1 - June 30) 2025 · District of Columbia · House · Senate · $60,000.00 income

Pharmacy, Medicare/Medicaid

View → Q2

CHECKMATE GOVERNMENT RELATIONS for GSK

2nd Quarter (Apr 1 - June 30) 2025 · District of Columbia · $50,000.00 income

Health Issues, Pharmacy

View → Q2

ISEMAN & ASSOCIATES LLC for TICHENOR VENTURES, LLC

2nd Quarter (Apr 1 - June 30) 2025 · Texas · House · Senate

Medical/Disease Research/Clinical Labs, Pharmacy, Aviation/Airlines/Airports, Budget/Appropriations

View → Q2

BIOGEN for BIOGEN

2nd Quarter (Apr 1 - June 30) 2025 · District of Columbia · House · Senate

Taxation/Internal Revenue Code, Manufacturing, Trade (domestic/foreign), Health Issues

View → Q2

HB STRATEGIES for BAYER U.S. LLC

2nd Quarter (Apr 1 - June 30) 2025 · New Jersey · House · Senate · $120,000.00 income

Agriculture, Pharmacy, Health Issues

View → Q2

CAPITOL COUNSEL LLC for EMD SERONO, INC.

2nd Quarter (Apr 1 - June 30) 2025 · Massachusetts · House · Senate · $50,000.00 income

Medicare/Medicaid, Pharmacy

View → Q2

CROSSROADS STRATEGIES, LLC for INDIVIOR INC.

2nd Quarter (Apr 1 - June 30) 2025 · California · House · Senate · $50,000.00 income

Pharmacy, Medicare/Medicaid

View → 2T

BL PARTNERS GROUP, LLC for ALBERTSONS COMPANIES, INC.

2nd Quarter (Apr 1 - June 30) 2025 · Illinois · House · Senate · $40,000.00 income

Pharmacy, Agriculture, Food Industry (safety, labeling, etc.)

View → Q2

RUBICON ADVISORS, LLC for APOE ALZHEIMERS ALLIANCE

2nd Quarter (Apr 1 - June 30) 2025 · Virginia · House · Senate · $20,000.00 income

Pharmacy

View → Q2

RUBICON ADVISORS, LLC for HENRY MEDS

2nd Quarter (Apr 1 - June 30) 2025 · Delaware · House · Senate · $60,000.00 income

Pharmacy

View → Q2

RUBICON ADVISORS, LLC for IMMUNIZATION ALLIANCE FOR EQUITY AND ACCESS

2nd Quarter (Apr 1 - June 30) 2025 · Virginia · $45,000.00 income

Pharmacy

View → Q2

RUBICON ADVISORS, LLC for ALZHEON

2nd Quarter (Apr 1 - June 30) 2025 · Massachusetts · $12,000.00 income

Pharmacy

View → Q2

RUBICON ADVISORS, LLC for HYPOPARATHYROIDISM ASSOCIATION

2nd Quarter (Apr 1 - June 30) 2025 · California

Pharmacy

View → Q2

RUBICON ADVISORS, LLC for ASCENDIS PHARMA, INC.

2nd Quarter (Apr 1 - June 30) 2025 · California · $60,000.00 income

Pharmacy

View → Q2

RUBICON ADVISORS, LLC for DR. REDDY'S LABORATORIES, LTD

2nd Quarter (Apr 1 - June 30) 2025 · New Jersey · House · Senate · $60,000.00 income

Pharmacy

View → Q2

RUBICON ADVISORS, LLC for DYNAVAX TECHNOLOGIES

2nd Quarter (Apr 1 - June 30) 2025 · California · House · Senate · $75,000.00 income

Pharmacy

View → Q2

TODD STRATEGY GROUP for GENENTECH, INC.

2nd Quarter (Apr 1 - June 30) 2025 · District of Columbia · House · Senate · $60,000.00 income

Medicare/Medicaid, Pharmacy

View → Q2

TODD STRATEGY GROUP for EMD SERONO INC.

2nd Quarter (Apr 1 - June 30) 2025 · District of Columbia · House · Senate · $50,000.00 income

Pharmacy, Health Issues

View → Q2

TODD STRATEGY GROUP for ASTELLAS PHARMA US, INC.

2nd Quarter (Apr 1 - June 30) 2025 · Illinois · House · Senate · $50,000.00 income

Pharmacy, Health Issues

View → Q2

MR. BRIAN KELLY for TAKEDA PHARMACEUTICAL COMPANY

2nd Quarter (Apr 1 - June 30) 2025 · Massachusetts · House · Senate · $10,000.00 income

Taxation/Internal Revenue Code, Pharmacy, Tariff (miscellaneous tariff bills), Trade (domestic/foreign)

View →